Semustine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Semustine
Semustine.png
Systematic (IUPAC) name
N-(2-Chloroethyl)-N'-(4-methylcyclohexyl)-N-nitrosourea
Identifiers
CAS Number 13909-09-6 YesY
ATC code L01AD03 (WHO)
PubChem CID 5198
ChemSpider 5009
UNII 6YY7T1T567 YesY
KEGG D05822 YesY
ChEBI CHEBI:6863 N
Chemical data
Formula C10H18ClN3O2
Molar mass 247.72 g/mol
 NYesY (what is this?)  (verify)

Semustine is a drug used in chemotherapy.[1] It is structurally similar to lomustine, being distinguished from it only by an additional methyl group. It has been taken off the drug market for investigation of its cancerous effects, rated as IARC Group 1 carcinogen or a known carcinogen.[2]

References[edit]

  1. ^ "Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group". Journal of Clinical Oncology. 10 (4): 549–557. 1992. PMID 1548520. 
  2. ^ http://www.cancer.org/cancer/cancercauses/othercarcinogens/generalinformationaboutcarcinogens/known-and-probable-human-carcinogens, Known and Probable Human Carcinogens, American Cancer Society